Medical device makers Abbott and Medtronic unveiled a global partnership that pairs Abbott's continuous glucose monitoring (CGM) sensors with the Medtronic insulin delivery system. The collaboration ...

DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

Back in the day – roughly around 2007, Medtronic offered a standalone continuous glucose monitoring system where diabetics who were not using a Medtronic insulin pump could use it to get continuous ...

(RTTNews) - Medtronic plc (MDT) announced the U.S. Food and Drug Administration approval for Simplera continuous glucose monitor, or CGM, the company's first disposable, all-in-one CGM that's half the ...

Abbott and Medtronic are typically regarded as competitors, but the two medical device giants have recently decided to join forces. Last week, the two companies teamed up to collaborate on a ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous glucose monitor, following a similar approval for the pairing in Europe early ...

GALWAY, Ireland, April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug ...

Medical leaders Medtronic and Abbott are collaborating on diabetes care in a new partnership that will combine technologies to expand options for patients. Medtronic is known for insulin pumps with ...

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience "Patients with diabetes can get overwhelmed by the sheer number of ...

Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology ...